6. Summary
Cutaneous candidiasis represents infections of the epidermis, primarily the stratum corneum of the skin, with C. albicans and occasionally certain non-C. albicans species. The condition known as chronic mucocutaneous candidiasis consists of a variety of syndromes with varying degrees of immune dysfunction and resulting chronic infections of the skin, nails, and mucous membranes with Candida organisms. The various forms of cutaneous candidiasis have a number of predispositions, such as warmth, moisture, and occlusion at the local site, various kinds of natural or iatrogenic immunosuppression, and perhaps some degree of inherited susceptibility. The immune system, particularly CMI, appears to be important in the defense against this type of infection. In the skin the mechanisms involved in generating immunologic reactions are particularly complex, with epidermal Langerhans cells, other dendritic cells, lymphocytes, microvascular endothelial cells, and the keratinocytes themselves all playing important roles. Studies of cutaneous candidiasis have elucidated a number of immunologic defects, which in some cases may be preexistent and in others may be secondary to the infection itself. Different mechanisms may cause immunologic dysfunction in individual patients and lead to the development of chronic infections. Although an inability to develop protective immune responses appears to be involved in the chronicity of certain cutaneous Candida infections, treatment at the present time depends primarily on antifungal medications; therapeutic modalities aimed at reversing the underlying immunologic defects remain experimental.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aderem, A.A. (1999). Mechanisms of phagocytosis in macrophages. Annu. Rev. Biochem. 17: 593–623.
Aderem, A.A. (2001). Role of toll-like receptors in inflammatory response in macrophages. Crit. Care Med. 29: S16–S18.
Alspaugh, J.A. and Granger, D.L. (1991). Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59: 2291–2296.
Arnold, R.R., Brewer, M., and Gauthier, J.J. (1980). Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms. Infect. Immun. 23: 893–898.
Arnold, R.R., Russell, J.E., Champion, W.J., and Gauthier, J.J. (1981). Bactericidal activity of human lactoferrin—influence of physical conditions and metabolic state of the target microorganism. Infect. Immun. 32: 655–660.
Axelsen, N.H., Kirkpatrick, C.H., and Buckley, R.H. (1974). Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gels. Clin. Exp. Immunol. 17: 385–394.
Berger, M., Kirkpatrick C.H., Goldsmith P.K., and Gallin, J.I. (1980). IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J. Immunol. 125: 2437–2443.
Bergstresser, P.R., Cruz, P.D. Jr., Niederkorn, J.Y., and Takashima, A. (1992). Third international workshop on Langerhans cells: Discussion overview. J. Invest. Dermatol. 99: 1S–4S.
Berk, S.H., Penneys, N.S., and Weinstein, G.D. (1976). Epidermal activity in annular dermatophytosis. Arch. Dermatol. 112: 485–488.
Berthou, C., Michel, L., Soulie, A., Jean-Louis, F., Flageul, B., Dubertret, L., Sigaux, F., Zhang, Y., and Sasportes, M. (1997). Acquisition of granzyme B and Fas ligand proteins by human keratinocyte contributes to epidermal cell defense. J. Immunol. 159: 5293–5300.
Bibel, D.J., Aly, R., and Shinefield, H.R. (1992). Antimicrobial activity of sphingosines. J. Invest. Dermatol. 98: 269–273.
Bibel, D.J., Aly, R., Shah, S., and Shinefield, H.R. (1993). Sphingosines: Antimicrobial barriers of the skin. Acta Derm. Venereol. (Stockh.) 73: 407–411.
Bice, D.E., Lopez, M., Rothschild, H., and Salvaggio, J. (1974). Comparison of Candida delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer. Int. Arch. Allergy Appl. Immunol. 47: 54–62.
Bjorses, P., Aaltonen, J., Horelli-Kuitunen, N., Yaspo, M.L., and Peltonen, L. (1998). Gene defect behind APECED: A new clue to autoimmunity. Hum. Mol. Genet. 7: 1547–1553.
Bjorses, P., Halonen, M., Palvimo, J.J., Kolmer, M., Aaltonen, J., Ellonen, P., Perheentupa, J., Ulmanen, I., and Peltonen, L. (2000). Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Human Gen. 66: 378–392.
Bos, J.D., Teunissen, M.B.M., Cairo, I., Krieg, S.R., Kapsenberg, M.L., Das, P.K., and Borst, J. (1990). T-cell receptor γδ bearing cells in normal human skin. J. Invest. Dermatol. 94: 37–42.
Buentke, E. and Scheynius, A. (2003). Dendritic cells and fungi. Acta Pathol. Microbiol. Immunol. Scand. 111: 789–796.
Burford-Mason, A.P., Matthews, R.C., and Williams, J.R.B. (1987). Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans. J. Infect. 14: 147–157.
Cahill, L.T., Ainbender, E., and Glade, P.R. (1974). Chronic mucocutaneous candidiasis: T cell deficiency associated with B cell dysfunction in man. Cell. Immunol. 14: 215–225.
Campanelli, D., Detmers, P.A., Nathan, C.F., and Gabay, J.E. (1990). Azuricidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 85: 904–915.
Carrow, E.W. and Domer, J.E. (1985). Immunoregulation in experimental murine candidiasis: Specific suppression induced by Candida albicans cell wall glycoprotein. Infect. Immun. 49: 172–181.
Cenci, E., Romani, L., Mencacci, A., Spaccapelo, R., Schiaftella, E., Pucetti, P., and Bistoni, F. (1993). Interleukin-4 and IL-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23: 1034–1038.
Chappler, R.R., Maibach, H.I., Conant, M.K.A., and Aly, R. (1978). Mucocutaneous candidiasis or mucocutaneous microbiosis? J. Am. Med. Assoc. 239: 428–429.
Chipps, B.E., Saulsbury, F.T., Hsu, S.H., Hughes, W.T., and Winkelstein, J.A. (1979). Non-Candida infections in children with chronic mucocutaneous candidiasis. Johns Hopkins Med. J. 144: 175–179.
Christin, L., Wysong, D.R., Meshulam, T., Wang, S., and Diamond, R.D. (1997). Mechanisms and target sites of damage in killing of Candida albicans hyphae by human polymorphonuclear neutrophils. J. Infect. Dis. 176: 1567–1578.
Collins, M.S. and Pappagianis, D. (1974). Inhibition by lysozyme of growth of the spherule phase of Coccioides immitis in vitro. Infect. Immun. 10: 616–623.
Cook, D.N., Hollingsworth, J.W. II, and Schwartz, D.A. (2003). Toll-like receptors and the genetics of innate immunity. Curr. Opin. Allergy Clin. Immunol. 3: 523–529.
Cutler, J.E. (1977). Chemotactic factor produced by Candida albicans. Infect. Immun. 18: 568–573.
De Bernardis, F., Mondello, F., San Millan, R., Ponton, J., and Cassone, A. (1999). Biotyping and virulence properties of skin isolates of Candida parapsilosis. J. Clin. Microbiol. 37: 3481–3486.
de la Torre Morin, F., Garcia Robaina, J.C., Bonnet Moreno, C., and Fonta, G.L. (1997). Hyper IgE syndrome. Presentation of three cases. Allergy Immunopathol. 25: 30–35.
De Moraes-Vasconcelos, D., Morii, N., Romano, C.C., Igueoka, R.Y., and da S. Duarte, A.J. (2001). Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis. Clin. Exp. Immunol. 123: 247–253.
Delves, P.J. and Riott, I.M. (2000). The immune system. N. Engl. J. Med. 343: 108–117.
Drouhet, E. and Dupont, B. (1980). Chronic mucocutaneous candidiasis and other superficial and systemic mycoses successfully treated with ketoconazole. Rev. Infect. Dis. 2: 606–619.
Durandy, A, Fischer, A., Le Deist, F., Drouhet, E., and Griscelli, C. (1987). Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J. Clin. Immunol. 7: 400–409.
Edens, H.A., Parkos, C.A., Liang, T.W., Jesaitis, A.J., Cutler, J.E., and Miettinen, H.M. (1999). Non-serum-dependent chemotactic factors produced by Candida albicans stimulate chemotaxis by binding to the formyl peptide receptor on neutrophils and to an unknown receptor on macrophages. Infect. Immun. 67: 1063–1071.
Elias, P.M. (1983). Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80: 44s–49s.
Elias, P.M. and Feingold, K.R. (1999). Skin as an organ of protection. In I.M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S.I. Katz, and T.B. Fitzpatrick (eds), Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, pp 164–174.
Eppinger, T.M., Aronson, J.E., Fonacier, L.S., and Cunningham-Rundles, C. (1999). Pneumocystis carinii pneumonia in a 15 year old with chronic mucocutaneous candidiasis. Scand. J. Infect. Dis. 31: 203–206.
Esterly, N.B., Brammer, S.R., and Crounse, R.G. (1967). The relationship of transferrin and iron to serum inhibition of Candida albicans. J. Invest. Dermatol. 49: 437–442.
Ferguson, A.C., Kershnar, H.E., Collin, W.K., and Stiehm, E.R. (1977). Correlation of cutaneous hypersensitivity with lymphocyte response to Candida albicans. Am. J. Clin. Pathol. 68: 499–504.
Fidel, P.L. Jr., Vazquez, J.A., and Sobel, J.D. (1999). Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12: 80–96.
Filler, S.G. and Edwards, J.E. Jr. (1993). Chronic mucocutaneous candidiasis. In J.W. Murphy, H. Friedman, and M. Bendinelli (eds), Fungal Infections and Immune Responses. Plenum Press, New York, pp. 117–133.
Fischer, A.J., Pichat, L., Audinot, M., and Griscelli, C. (1982). Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin. Exp. Immunol. 47: 653–660.
Fischer, A.J., Ballet, J.J., and Griscelli, C. (1987). Specific inhibition of the in vitro Candidainduced lymphocyte proliferation by polysaccharide antigens present in the serum of patients with chronic mucocutaneous candidiasis. J. Clin. Invest. 62: 1005–1013.
Frohm, M., Agerberth, B., Ahangari, G., Stahle-Backdahl, M., Liden, S., Wigzell, H., and Gudmundsson, G.H. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272: 15258–15263.
Ganz, T., Selsted, M.E., Szklarek, D., Harwig, S.S.L., Dahler, K., Bainton, D.F., and Lehrer, R.I. (1985). Defensins: Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76: 1427–1435.
Gavira, J.M., van Burik, J.A., Dale, D.C., Root, R.K., and Liles, W.C. (1999). Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J. Infect. Dis. 179: 1301–1304.
Geerlings, S.E. and Hoepelman, A.I. (1999). Immune dysfunction in patients with diabetes mellitus. FEMS Immunol. Med. Microbiol. 26: 259–265.
Gettner, S.M.M. and Mackenzie, D.W.R. (1981). Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans. J. Med. Microbiol. 14: 333–340.
Grisham, M.B., Jefferson, M.M., Melton, D.F., and Thomas, E.L. (1983). Chlorination of exogenous amines by isolated neutrophils. Ammonia dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J. Biol. Chem. 258: 10404–10413.
Haake, A.R. and Holbrook, K. (1999). The structure and development of the skin. In I.M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S.I. Katz, and T.B. Fitzpatrick (eds), Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, pp 70–97.
Hackett, C.J. (2003). Innate immune activation as a broad-spectrum biodefense strategy—perspectives and research challenges. J. Allergy Clin. Immunol. 112: 686–694.
Herrod, H.G. (1990). Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection—a report of the pediatric immunodeficiency study group. J. Pediatr. 116: 377–382.
Heymann, P., Gerads, M., Schaller, M., Dromer, F., Winkelmann, G., and Ernst, J.F. (2002). The siderophore iron transporter of Candida albicans (Sit1P/Arn1P) mediates uptake of ferrichrometype siderophores and is required for epithelial invasion. Infect. Immun. 70: 5246–5255.
Ho, Y., Ng, M., and Huang, C.T. (1979). Antibodies to germinating and yeast cells of Candida albicans in human and rabbit sera. J. Clin. Pathol. 32: 399–405.
Joualt, T., Ibaya-Ombetto, S., Takeuchi, O., Trinel, P.A., Sacchetti, P., Lefebvre, P., Akira, S., and Poulain, D. (2003). Candida albicans phosphomannan is sensed through toll-like receptors. J. Infect. Dis. 188: 165–172.
Kalfa, V.C., Roberts R.L., and Steihm, E.R. (2003). The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency. Ann. Allergy Asthma Immunol. 90: 259–264.
Kashima, M., Takahashi, H., Shimozuma, M., Epstein, W.L., and Fukuyama, K. (1989). Candidacidal activities of proteins partially purified from rat epidermis. Infect. Immun. 57: 186–190.
Kauffman, C.A., Shea, M.J., and Frame, P.R. (1981). Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch. Intern. Med. 141: 1076–1078.
Kirkpatrick, C.H. and Smith, T.K. (1974). Chronic mucocutaneous candidiasis: Immunologic and antibiotic therapy. Ann. Intern. Med. 80: 310–320.
Kirkpatrick, C.H. and Sohnle, P.G. (1981). Chronic mucocutaneous candidiasis. In B. Safai and R.A. Good (eds), Immunodermatology. Plenum Press, New York, pp. 495–514.
Kirkpatrick, C.H. and Windhorst, D.B. (1979). Mucocutaneous candidiasis and thymoma. Am. J. Med. 66: 939–945.
Kirkpatrick, C.H., Rich, R.R., and Bennett, J.E. (1971). Chronic mucocutaneous: Model building in cellular immunity. Ann. Intern. Med. 74: 955–978.
Kligman, A.M. and Ginsberg, D. (1950). Immunity of the adult scalp to infection with Microsporum audouini. J. Invest. Dermatol. 14: 345–356.
Lehner, T.J., Wilton, M.A., and Ivanyi, L. (1972). Immunodeficiencies in chronic mucocutaneous candidiasis. Immunology 22: 775–787.
Lepper, A.W.D. and Anger, H.S. (1976). Experimental bovine Trichophyton verrucosum infection. Comparison of the rate of epidermal cell proliferation and keratinization in non-infected and reinoculated cattle. Res. Vet. Sci. 20: 117–121.
Lilic, D., Cant, A.J., Abinum, M., Calvert, J.E., and Spickett, G.P. (1996). Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL 2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production. Clin. Exp. Immunol. 105: 205–212.
Lilic, D., Gravenor, I., Robson, N., Lammas, D.A., Drysdale, P., Calvert, J.E., Cant, A.J., and Abinun, M. (2003). Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect. Immun. 71: 5690–5699.
Liu, L., Wang, L., Jia, H.P., Zhao, C., Heng, H.H.Q., Schutte, B.C., McCray, P.B. Jr., and Ganz, T. (1998). Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 222: 237–244.
Liu, L., Roberts, A.A., and Ganz, T. (2003). By IL-1 signaling, monocytic-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J. Immunol. 170: 575–580.
Mackintosh, J.A. (2001). The antimicrobial properties of melanocytes, melanosomes, and melanin, and the evolution of black skin. J. Theor. Biol. 211: 101–113.
Madsen, P., Rasmussen, H.H., Leffers, H., Honore, B., and Celis, J.E. (1992). Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein) that is highly upregulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol. 99: 299–305.
Marodi, L., Tournay, C., Kaposzta, R., Johnston, R.B. Jr., and Moguilevsky, N. (1998). Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 66: 2750–2754.
Marr, K.A., Balajee, S.A., Hawn, T.R., Ozinsky, A., Phom, U., Akira, S., Aderem, A., and Liles, W.C. (2003). Differential roles of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect. Immun. 71: 5280–5286.
Martinez, A., Elsasser, T.H., Muro-Cacho, C., Moody, T.W., Miller, M.J., Macri, C.J., and Cuttitta, F. (1997). Expression of adrenomedullin and its receptor in normal and malignant human skin: A potential pluripotent role in the integument. Endocrinology 138: 5597–5604.
Matsue, H., Bergstresser, P.R., and Takashima, A. (1993). Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J. Immunol. 151: 6012–6019.
Miller, S.J., Aly, R., Shinefield, H.R., and Elias, P.M. (1988). In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch. Dermatol. 124: 209–215.
Mittaz, L., Rossier, C., Heino, M., Peterson, P., Krohn, K.J., Gos, A., Morris, M.A., Judoh, J., Shimizu, N., Antonarakis, S.E., and Scott, H.S. (1999). Isolation and characterization of the mouse AIRE gene. Biochem. Biophys. Res. Comm. 255: 483–490.
Mobacken, H., Lindholm, L., and Olling, S. (1977). Deficient neutrophil function in a patient with chronic mucocutaneous candidiasis, thymoma and myasthenia gravis. Acta Derm. Venereol. 57: 335–339.
Moser, S.A., Domer, J.E., and Mather, F.J. (1980). Experimental murine candidiasis: Cell-mediated immunity after cutaneous challenge. Infect. Immun. 27: 140–149.
Mosmann, T.R. and Sad, S. (1996). The expanding universe of T cell subsets: Th1, Th2 and more. Immunol. Today 17: 138–146.
Nauseef, W.M. and Clark, R.A. (2000). Granulocytic phagocytes. In G.L. Mandel, J.E. Bennett, and R. Dolin (eds), Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia, pp. 89–112.
Negi, M., Tsuboi, R., Matsui, T., and Ogawa, H. (1984). Isolation and characterization of proteinase from Candida albicans—substrate specificity. J. Invest. Dermatol. 83: 32–36.
Neth, O., Jack, D.L., Dodds, A.W., Holzel, H., Klein, N.J., and Turner, M.W. (2000). Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68: 688–693.
Nguyen, C. and Katner, H.P. (1997). Myeloperoxidase deficiency manifesting as pustular candidal dermatitis. Clin. Infect. Dis. 24: 258–260.
Ong, P.Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R.L., and Leung, D.Y.M. (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347: 1151–1160.
Podzorski, R.P., Gray, G.R., and Nelson, R.D. (1990). Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J. Immunol. 144: 707–716.
Potten, C.S. (1974). The epidermal proliferative unit—the possible role of the central basal cell. Cell Tissue Kinet. 7: 77–88.
Radke, L.L., Hahn, B.L., Wagner, D.K., and Sohnle, P.G. (1994). Comparison of metal-binding antimicrobial activities in serum and abscess fluid supernatants. J. Med. Veter. Mycol. 32: 295–301.
Ray, T.L. and Wuepper, K.D. (1976). Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J. Invest. Dermatol. 67: 700–703.
Ring, J. and Thewes, M. (1999). The clinical expression of allergy in the skin. Allergy 54: 192–197.
Rivas, V. and Rogers, T.J. (1983). Studies on the cellular nature of Candida albicans—induced suppression. J. Immunol. 130: 376–379.
Rodriguez-Adrian, L.J., Grazziutti, M.L., Rex, J.H., and Anaissie, E.J. (1998). The potential role of cytokine therapy for fungal infections in patients with cancer—is recovery from neutropenia all that is needed? Clin. Infect. Dis. 26: 1270–1278.
Rogers, T.J. and Balish, E. (1978). Suppression of lymphocyte blastogenesis by Candida albicans. Clin. Immunol. Immunopathol. 10: 298–305.
Roilides, E., Kadiltsoglou, I., Dimitriadou, A., Hatzistilianou, M., Manitsa, A., Karpouzas, J., Pizzo, P.A., and Walsh, T.J. (1997). Interleukin 4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia. FEMS Immunol. Med. Microbiol. 19: 169–180.
Romani, L. (1999). Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2: 363–367.
Rosatelli, M.C., Meloni, A., Meloni, A., Devoto, M., Cao, A., Scott, H.S., Peterson, P., Heino, M., Krohn, K.J., Nagamine, K., Kodoh, J., Shimizu, N., and Antonarakis, S.E. (1998). A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum. Genet. 103: 428–434.
Rothman, S., Smiljanic, A., Shapiro, A.L., and Weitkamp, A.W. (1947). The spontaneous cure of tinea capitis in puberty. J. Invest. Dermatol. 8: 81–98.
Rothschild, H., Wilson, M., Lopez, M., Salvaggio, J., and Bice, D. (1976). An immunological investigation of a family with chronic mucocutaneous candidiasis. Int. Arch. Allergy Appl. Immunol. 52: 291–296.
Schmitt, C. and Ballet, J.J. (1983). Serum IgE and IgG antibodies to tetanus toxoid and candidin in immunodeficient children with the hyper-IgE syndrome. J. Clin. Immunol. 3: 178–183.
Schroder, J.M. and Harder, J. (1999). Human beta-defensin 2. Int. J. Biochem. Cell Biol. 31: 645–651.
Schurer, N.Y. and Elias, P.M. (1991). The biochemistry and function of stratum corneum lipids. Adv. Lipid Res. 24: 27–56.
Siegenthaler, G., Roulin, K., Chatellard-Gruaz, D., Hotz, R., Saurat, J.H., Hellman, U., and Hagens, G. (1997). A heterocomplex formed by the calcium-binding proteins MRP 8 (S100A8) and MRP 14 (S100A9) binds unsaturated fatty acids with high affinity. J. Biol. Chem. 272: 9371–9377.
Sohnle, P.G. (1997). Antimicrobial defence through competition for zinc. Rev. Med. Microbiol. 8: 217–234.
Sohnle, P.G. and Hahn, B.L. (1989). Epidermal proliferation and the neutrophilic infiltrates of experimental cutaneous candidiasis in mice. Arch. Dermatol. Res. 281: 279–283.
Sohnle, P.G. and Kirkpatrick, C.H. (1978). Epidermal proliferation in the defense against cutaneous candidiasis. J. Invest. Dermatol. 70: 130–133.
Sohnle, P.G., Frank, M.M., and Kirkpatrick, C.H. (1976). Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infection in guinea pigs. J. Immunol. 117: 523–530.
Sohnle, P.G., Collins-Lech, C., and Huhta, K.E. (1983). Kinetics of lymphokine production by lymphocytes from elderly humans. Gerontology 29: 169–175.
Sohnle, P.G., Collins-Lech, C., and Wiessner, J.H. (1991). The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J. Infect. Dis. 164: 137–142.
Steinbakk, M., Naess-Andresen, C.F., Lingass, E., Dale, I., Brandtzaeg, P., and Fagerhol, M.K. (1990). Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336: 763–765.
Stengaard-Pedersen, K., Thiel, S., Gadjeva, M., Moller-Kristensen, M., Sorensen, R., Jensen, L.T., Sjoholm, A.G., Fugger, L., and Jensenius, J.C. (2003). Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med. 349: 554–560.
Stevens, D.A. (1998). Combination immunotherapy and antifungal chemotherapy. Clin. Infect. Dis. 26: 1266–1269.
Stingl, G. (1993). This skin: Initiation and target site of immune responses. Recent Results Cancer Res. 128: 45–57.
Stingl, G., Maurer, D., Hauser, C., and Wolff, K. (1999). The epidermis-an immunologic microenvironment. In I.M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S.I. Katz, and T.B. Fitzpatrick (eds), Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, pp. 343–370.
Streilein, J.W. (1983). Skin-associated lymphoid tissues (SALT)—origins and functions. J. Invest. Dermatol. 80: 12S–16S.
Sundstrom, P.M. and Kenny, G.E. (1984). Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence. Infect. Immun. 43: 850–855.
Tada, H., Nemoto, E., Shimauchi, H., Watanabe, T., Mikami, T., Matsumato, T., Ohno, N., Tamura, H., Shibata, K., Akashi, S., Miyake, K., Sugawara, S., and Takada, H. (2002). Saccharomyces cerevisae-and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and toll-like receptor 4-dependent manner. Microbiol. Immunol. 46: 503–512.
Tagami, H. (1992). The role of complement-derived mediators in inflammatory skin diseases. Arch. Dermatol. Res. 284(Suppl. 1): S2–S9.
Test, S.T., Lampert, M.B., Ossanna, P.J., Thoene, J.G., and Weiss, S.J. (1984). Generation of nitrogen-chlorine oxidants by human phagocytes. J. Clin. Invest. 74: 1341–1349.
Twomey, J.T., Waddel, C.C., Krantz, S., O’Reilly, R., L’Esperance, P., and Good, R.A. (1975). Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor and coexistent aplastic anemia. J. Lab. Clin. Med. 85: 968–977.
Valdimarsson, H., Higgs, J.M., Wells, R.S., Yamamura, M., Hobbs, J.R., and Holt, P.J.L. (1973). Immune abnormalities associated with chronic mucocutaneous. Cell Immunol. 6: 348–361.
Vazquez, N., Walsh, T.J., Friedman, D., Chanock, S.J., and Lyman, C.A. (1998). Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun. 66: 145–150.
Weiss, J., Elsbach, P., Olsson, I., and Odeberg, H. (1978). Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253: 2664–2672.
Wiedow, O., Harder, J., Bartels, J., Streit, V., and Christophers, E. (1998). Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes. Biochem. Biophys. Res. Commun. 248: 904–909.
Wilson, B.D. and Sohnle, P.G. (1986). Participation of neutrophils and cell-mediated immunity in the defense against experimental cutaneous candidiasis in mice. Am. J. Pathol. 123: 241–249.
Wilson, B.D. and Sohnle, P.G. (1988). Neutrophil accumulation and cutaneous responses in experimental cutaneous candidiasis of genetically complement-deficient mice. Clin. Immunol. Immunopathol. 46: 284–293.
Zanetti, M., Gennaro, R., and Romeo, D. (1996). Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374: 1–5.
Zuccarello, D., Salpietro, D.C., Gangemi, S., Toscano, V., Merlino, M.V., Briuglia, S., Bisignano, G., Mangino, M., Mingarelli, R., and Dallapiccola, B. (2002). Familial chronic nail candidiasis with ICAM-1 deficiency—a new form of chronic mucocutaneous candidiasis. J. Med. Genet. 39: 671–675.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Srinivasan, S., Wagner, D.K., Sohnle, P.G. (2005). Immunology of Cutaneous Candidiasis. In: Fidel, P.L., Huffnagle, G.B. (eds) Fungal Immunology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25445-5_21
Download citation
DOI: https://doi.org/10.1007/0-387-25445-5_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24092-3
Online ISBN: 978-0-387-25445-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)